Study to evaluate the optimal dose of ⁶⁸ Ga-OPS202 as a PET imaging agent in patients with GEP-NETs

It's almost like getting free consulting...

Subscribe to our monthly hand-crafted newsletter for the latest insights on clinical trial trends and the life science industry.

Subscribe Now